ToxStrategies (Renovus-backed) Acquires Modality Solutions

Renovus-Backed BlueRidge Life Sciences Formed by Uniting Suttons Creek, Modality Solutions, CLINTREX and ToxStrategies

August 25, 2025

Healthcare Services

Four life-sciences consulting firms — Suttons Creek, Modality Solutions, CLINTREX, and ToxStrategies — have been unified under the new brand BlueRidge Life Sciences to create an integrated life-sciences services platform. The move, backed by private equity sponsor Renovus Capital Partners, consolidates toxicology, regulatory science, engineering, clinical research and related capabilities to offer end-to-end scientific and regulatory support to pharmaceutical, biotech, medical device and consumer-product clients.

ICT Group Acquires Modality

February 12, 2025

Software

ICT Group has acquired Modality, a Dutch software firm specializing in intermodal freight transport systems (TMS/TOS). The deal strengthens ICT Group’s Logistics division, expands its capabilities in the seaport–hinterland logistics chain, and supports further growth across the Benelux and DACH regions while Modality continues to operate under its current management.

Atomic Transport Acquires Modern Transport Solutions

January 23, 2025

Environmental Services

Atomic Transport, a Chattanooga-based bulk-material transport and transfer-station operator, has acquired Modern Transport Solutions, which operates transfer and transportation services in Arizona and Colorado. The deal closed January 23, 2025 and expands Atomic's geographic footprint and service capabilities to better serve nationwide customers.

ToxStrategies Acquires Suttons Creek

August 13, 2024

Healthcare Services

ToxStrategies, a Renovus Capital Partners portfolio company, has acquired Suttons Creek to expand its combination-product development and regulatory consulting capabilities. Brookside Capital Partners provided financing to support the add-on acquisition; Suttons Creek will operate as a division of ToxStrategies and its founder Steven Badelt will continue to lead the business. Terms were not disclosed.

ToxStrategies Acquires Clintrex Research Corporation

June 25, 2024

Healthcare Services

ToxStrategies, a Renovus Capital Partners–backed scientific consulting firm based in Katy, Texas, has acquired Clintrex Research Corporation, a Sarasota-based clinical and regulatory development services provider focused on neurodegenerative and CNS therapies. The deal (terms undisclosed) expands ToxStrategies' clinical, regulatory, biostatistics and drug‑development capabilities and is intended to broaden its end‑market reach in the life sciences sector.

Renovus Capital Partners Majority Investment in ToxStrategies

January 24, 2023

Healthcare Services

Renovus Capital Partners made a majority investment in ToxStrategies, a multidisciplinary scientific consulting firm specializing in toxicology, epidemiology, exposure sciences and regulatory compliance. Five Points Capital provided debt and equity co-investment to support the transaction; terms were not disclosed and the deal was described as a recapitalization to support growth and expand services, staff and geographic reach.